期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Fas/Fasl表达与肺癌细胞凋亡关系的研究进展 被引量：2

下载PDF
导出
作者 杨景伟 王明钊 沈毅
机构地区 青岛大学医学院附属医院
出处 《山东医药》 CAS 北大核心 2006年第27期91-92,共2页 Shandong Medical Journal
基金 青岛市科技局资助项目(03-1-NY-14-2)
关键词 Fas基因蛋白 Fasl基因蛋白 细胞凋亡 肺肿瘤
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Viard-Leveugle I, Veyrenc S,French LE,et al. Frequent loss of Fas expression and function in human lung tumours with over expression of FasL in small cell lung carcinoma [J]. Pathol,2003,201(2):268-277.
  • 2Maher S,Toomey D, Condron C,et al. Activation induced cell death: thecontroversial role of Fas and Fas ligand in immune privilege and turnout conterattack[J]. Immunol Cell Biol,2002,80(2):131-137.
  • 3Shin MS, Kim HS, Lee SH, et al. Alterations of Fas pathway genes associated with nodal metastasis in non small cell lung cancer[J]. Oncogene, 2002,21 (26) :4129-4136.
  • 4Liu K,Scott I, Abrams SI, et al. Alterations in Fas expression are characteristic of, but not solely responsible for enhanced metastatic competence[J]. Immunol, 2003,170(12) : 5973-5978.
  • 5Pluygers E, Sadowska A,Chyczewski L, et al. The impact of immune response on lung cancer and the development of new treatment modalities[J]. Lung Cancer,2001,34(Suppl2) :71-77.
  • 6Cho D, Song H, Kim YM, et al. Endogenous interleukin 18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates[J].Cancer Res,2000,60(10):2703-2709.
  • 7Raez LE, Cassileth PA,Schlesselman JJ ,et al. Allogeneic vaccination with a BT. 1 HLA-A gene-modified adenoeareinoma cell line in patients with advanced non-small-cell lung cancer[J].Clin Oncol,2004,22(14):2800-2807.
  • 8江中勇,杨凌,陈清勇.Fas/FasL与肺癌关系的研究进展[J].国外医学（呼吸系统分册）,2005,25(2):115-117. 被引量：4
  • 9Odoux C,Albers A,Amoscato AA,et al. TRAIL,Fasl and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer[J]. Int J Cancer, 2002,97(4):458-465.
  • 10时玉舫．细胞生物学与肿瘤免疫学研究进展[M]．北京：军事医学科学出版社，2000，10—23．

二级参考文献16

  • 1O'Connele LL,Bennett MW,O'Sullivan GC,et al.The Fascounter attack: cancer as a site of immuneprivilege.Immunol Today,1999,20(1):46-52.
  • 2Shin MS,Kim HS,Lee SH,et al.Alterations of Fas-pathway genes associated with nodal metastasis in non-small cell lung cancer.Oncogene,2002,21(26):4129-4136.
  • 3Bernstorff WV,Spamjaard RA,Chan AK,et al.Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas(Apo-1/CD95) recepors and sberrant expression of functional Fas ligand.Surgery,1999,125(1):73-84.
  • 4Bennett MW,O'Connele LL,O'Sullivan GC,et al.The Fascounter attack in vivo:apoptotic depletion of tumor infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.J Immunol,1998,160(11):5669-5675.
  • 5Arai H,Chan SY,Bishop DK,et al.Inhibition of the alloantibody response by CD95 ligand.Nat Med,1997,3(8):843-848.
  • 6Rabinowich H,Reichert TE,Kashii Y,et al.Lymphocyte apoptosis induced by Fas ligand-expressing Ovarian carainoma cells.J Clin Invest,1998,101(11):2579-2588.
  • 7Cho D,Song H,Kim YM,et al.Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates.Cancer Res,2000,60(10):2703-2709.
  • 8Viard-Leveugle I,Veyrenc S,French LE.Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.J Pathol,2003,201(2):268-277.
  • 9Dong Xilin,Dong Lei,Li Xiuxia,et al.The expression and Clinical Significance of Fas and FasL in Lung Cancer.J Med University,2003,17(3):122-128.
  • 10Odoux C,Albers A,Amoscato AA,et al.TRAIL,FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer.Int J Cancer,2002,97(4):458-465.

共引文献3

同被引文献11

引证文献2

二级引证文献22

山东医药
2006年 第27期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部